Cargando…

Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation

[Image: see text] Prolonged exposure to opioid receptor agonists triggers adaptations in the adenylyl cyclase (AC) pathway that lead to enhanced production of cyclic adenosine monophosphate (cAMP) upon withdrawal. This cellular phenomenon contributes to withdrawal symptoms, hyperalgesia and analgesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Ahmed, Nagi, Karim, Dallaire, Paul, Lukasheva, Viktoriya, Le Gouill, Christian, Bouvier, Michel, Pineyro, Graciela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506601/
https://www.ncbi.nlm.nih.gov/pubmed/34661070
http://dx.doi.org/10.1021/acsptsci.1c00019
_version_ 1784581731408412672
author Mansour, Ahmed
Nagi, Karim
Dallaire, Paul
Lukasheva, Viktoriya
Le Gouill, Christian
Bouvier, Michel
Pineyro, Graciela
author_facet Mansour, Ahmed
Nagi, Karim
Dallaire, Paul
Lukasheva, Viktoriya
Le Gouill, Christian
Bouvier, Michel
Pineyro, Graciela
author_sort Mansour, Ahmed
collection PubMed
description [Image: see text] Prolonged exposure to opioid receptor agonists triggers adaptations in the adenylyl cyclase (AC) pathway that lead to enhanced production of cyclic adenosine monophosphate (cAMP) upon withdrawal. This cellular phenomenon contributes to withdrawal symptoms, hyperalgesia and analgesic tolerance that interfere with clinical management of chronic pain syndromes. Since δ-opioid receptors (DOPrs) are a promising target for chronic pain management, we were interested in finding out if cell-based signaling profiles as generated for drug discovery purposes could inform us of the ligand potential to induce sensitization of the cyclase path. For this purpose, signaling of DOPr agonists was monitored at multiple effectors. The resulting signaling profiles revealed marked functional selectivity, particularly for Met-enkephalin (Met-ENK) whose signaling bias profile differed from those of synthetic ligands like SNC-80 and ARM390. Signaling diversity among ligands was systematized by clustering agonists according to similarities in E(max) and Log(τ) values for the different responses. The classification process revealed that the similarity in Gα/Gβγ, but not in β-arrestin (βarr), responses was correlated with the potential of Met-ENK, deltorphin II, (d-penicillamine2,5)-enkephalin (DPDPE), ARM390, and SNC-80 to enhance cAMP production, all of which required Ca(2+) mobilization to produce this response. Moreover, superactivation by Met-ENK, which was the most-effective Ca(2+) mobilizing agonist, required Gαi/o activation, availability of Gβγ subunits at the membrane, and activation of Ca(2+) effectors such as calmodulin and protein kinase C (PKC). In contrast, superactivation by (N-(l-tyrosyl)-(3S)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-l-phenylalanyl-l-phenylalanine (TIPP), which was set in a distinct category through clustering, required activation of Gαi/o subunits but was independent of the Gβγ dimer and Ca(2+) mobilization, relying instead on Src and Raf-1 to induce this cellular adaptation.
format Online
Article
Text
id pubmed-8506601
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-85066012022-09-09 Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation Mansour, Ahmed Nagi, Karim Dallaire, Paul Lukasheva, Viktoriya Le Gouill, Christian Bouvier, Michel Pineyro, Graciela ACS Pharmacol Transl Sci [Image: see text] Prolonged exposure to opioid receptor agonists triggers adaptations in the adenylyl cyclase (AC) pathway that lead to enhanced production of cyclic adenosine monophosphate (cAMP) upon withdrawal. This cellular phenomenon contributes to withdrawal symptoms, hyperalgesia and analgesic tolerance that interfere with clinical management of chronic pain syndromes. Since δ-opioid receptors (DOPrs) are a promising target for chronic pain management, we were interested in finding out if cell-based signaling profiles as generated for drug discovery purposes could inform us of the ligand potential to induce sensitization of the cyclase path. For this purpose, signaling of DOPr agonists was monitored at multiple effectors. The resulting signaling profiles revealed marked functional selectivity, particularly for Met-enkephalin (Met-ENK) whose signaling bias profile differed from those of synthetic ligands like SNC-80 and ARM390. Signaling diversity among ligands was systematized by clustering agonists according to similarities in E(max) and Log(τ) values for the different responses. The classification process revealed that the similarity in Gα/Gβγ, but not in β-arrestin (βarr), responses was correlated with the potential of Met-ENK, deltorphin II, (d-penicillamine2,5)-enkephalin (DPDPE), ARM390, and SNC-80 to enhance cAMP production, all of which required Ca(2+) mobilization to produce this response. Moreover, superactivation by Met-ENK, which was the most-effective Ca(2+) mobilizing agonist, required Gαi/o activation, availability of Gβγ subunits at the membrane, and activation of Ca(2+) effectors such as calmodulin and protein kinase C (PKC). In contrast, superactivation by (N-(l-tyrosyl)-(3S)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl)-l-phenylalanyl-l-phenylalanine (TIPP), which was set in a distinct category through clustering, required activation of Gαi/o subunits but was independent of the Gβγ dimer and Ca(2+) mobilization, relying instead on Src and Raf-1 to induce this cellular adaptation. American Chemical Society 2021-09-09 /pmc/articles/PMC8506601/ /pubmed/34661070 http://dx.doi.org/10.1021/acsptsci.1c00019 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mansour, Ahmed
Nagi, Karim
Dallaire, Paul
Lukasheva, Viktoriya
Le Gouill, Christian
Bouvier, Michel
Pineyro, Graciela
Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title_full Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title_fullStr Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title_full_unstemmed Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title_short Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation
title_sort comprehensive signaling profiles reveal unsuspected functional selectivity of δ-opioid receptor agonists and allow the identification of ligands with the greatest potential for inducing cyclase superactivation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506601/
https://www.ncbi.nlm.nih.gov/pubmed/34661070
http://dx.doi.org/10.1021/acsptsci.1c00019
work_keys_str_mv AT mansourahmed comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT nagikarim comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT dallairepaul comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT lukashevaviktoriya comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT legouillchristian comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT bouviermichel comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation
AT pineyrograciela comprehensivesignalingprofilesrevealunsuspectedfunctionalselectivityofdopioidreceptoragonistsandallowtheidentificationofligandswiththegreatestpotentialforinducingcyclasesuperactivation